Finance

Lists
Why is 424870 down ५.५६%?
Dive Deeper
424870:KOSDAQ
ImmuneOncia Therapeutics Inc
₩ २,३८०.००
-५.५६%
(-१४०.००) 1D
नोभेम्बर ६, १५:३०:३० GMT+९  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 424870...
Open
₩ २,३५०
High
₩ २,४७०
Low
₩ २,३३०
Mkt. cap
२.१८ खरब
Avg. vol.
७.८१ लाख
Volume
२.५३ लाख
52-wk high
₩ १४,९६४
52-wk low
₩ २,३००
EPS
-₩ ३८०
Shares outstanding
९.१४ करोड
No. of employees
२६
Open
₩ २,३५०
High
₩ २,४७०
Low
₩ २,३३०
Mkt. cap
२.१८ खरब
Avg. vol.
७.८१ लाख
Volume
२.५३ लाख
52-wk high
₩ १४,९६४
52-wk low
₩ २,३००
EPS
-₩ ३८०
Shares outstanding
९.१४ करोड
No. of employees
२६
News stories
From web sources and news partners
Marin Independent Journal
Marin Independent Journal
·
२० मिनेट पहिले
Nasdaq stumbles are worrisome for California economy
Seeking Alpha
Seeking Alpha
·
३६ मिनेट पहिले
The Path Forward After This Mini-Meltdown
CNBC
CNBC
·
१ घण्टा पहिले
Opening Bell: November 6, 2026
CNN
CNN
·
६ घण्टा पहिले
What sparked the stock market’s $2.5 trillion sell-off?
About ImmuneOncia Therapeutics Inc
CEO-
Employees२६
Founded२०१६
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
४०.६६ लाख
२८.७५ लाख
३४.९८ लाख
३९.३७ लाख
Cost of revenue
४०.६६ लाख
२८.७५ लाख
३४.९८ लाख
३९.३७ लाख
Research and development expenses
९.२९ अरब
८.३१ अरब
४.५१ अरब
२.८५ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.११ अरब
१.०६ अरब
१.०४ अरब
१.२४ अरब
Operating expense
१०.५९ अरब
९.५६ अरब
५.७५ अरब
४.२७ अरब
Total operating expenses
१०.६० अरब
९.५७ अरब
५.७५ अरब
४.२७ अरब
Operating income
-१०.६० अरब
-९.५७ अरब
-५.७५ अरब
-४.२७ अरब
Other non operating income
-३.५५ करोड
-१.५३ करोड
-८.०८ लाख
-१०.९० लाख
EBT including unusual items
-१०.३७ अरब
-९.४१ अरब
-५.६२ अरब
-३.९० अरब
EBT excluding unusual items
-१०.३७ अरब
-९.४१ अरब
-५.६२ अरब
-३.९० अरब
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
२५.३९ लाख
६३.६२ लाख
१.८० करोड
४६.६१ लाख
Net income
-१०.३७ अरब
-९.४१ अरब
-५.६२ अरब
-३.९० अरब
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
२४.५३ करोड
२०.६७ करोड
१६.२६ करोड
४१.६३ करोड
Interest expense
-१२.८५ लाख
-१२.०९ लाख
-९.९५ लाख
-७.७९ लाख
Net interest expenses
२४.४० करोड
२०.५५ करोड
१६.१६ करोड
४१.५५ करोड
Depreciation and amortization charges
४.१० करोड
४.०३ करोड
३.८५ करोड
३.७३ करोड
EBITDA
-१०.३३ अरब
-९.३४ अरब
-५.५३ अरब
-४.०६ अरब
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू